Literature DB >> 29804199

Identification of a novel GREM1 duplication in a patient with multiple colon polyps.

Danielle B McKenna1, Jeroen Van Den Akker2, Alicia Y Zhou2, Lauren Ryan2, Annette Leon2, Robert O'Connor2, Payal D Shah1, Anil K Rustgi3, Bryson W Katona4.   

Abstract

Hereditary mixed polyposis syndrome (HMPS) is a hereditary syndrome that is characterized by multiple colon polyps of mixed pathologic subtypes and an increased risk for colorectal cancer. A 40 kb duplication in the 5' regulatory region of the GREM1 gene was recently found to be the causal mutation in a subset of Ashkenazi Jewish families with HMPS. Given this discovery, the GREM1 5' regulatory region is now analyzed on many different multi-gene cancer panels, however the data on duplications distinct from the 40 kb duplication remains minimal. Herein we report a novel 24 kb tandem duplication of the 5' regulatory region of GREM1 in a patient without Ashkenazi Jewish heritage, who had a family history that was concerning for Lynch syndrome and satisfied Amsterdam II criteria. This is only the third reported GREM1 duplication separate from the 40 kb Ashkenazi Jewish duplication, and is the only reported duplication to selectively involve exon 1 of GREM1. This finding supports comprehensive testing of the GREM1 regulatory region in families of all ethnicities with multiple colon polyps or colon cancer, and when Lynch syndrome is suspected.

Entities:  

Keywords:  Colon polyps; GREM1; Hereditary mixed polyposis syndrome

Mesh:

Substances:

Year:  2019        PMID: 29804199      PMCID: PMC6261785          DOI: 10.1007/s10689-018-0090-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  11 in total

1.  Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients.

Authors:  Ramprasath Venkatachalam; Eugène T P Verwiel; Eveline J Kamping; Eveline Hoenselaar; Heike Görgens; Hans K Schackert; J Han J M van Krieken; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge; Ad Geurts van Kessel; Roland P Kuiper
Journal:  Int J Cancer       Date:  2011-04-04       Impact factor: 7.396

2.  Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.

Authors:  Sari Lieberman; Tom Walsh; Menachem Schechter; Tomer Adar; Eran Goldin; Rachel Beeri; Nitzan Sharon; Hagit Baris; Liat Ben Avi; Elizabeth Half; Israela Lerer; Brian H Shirts; Colin C Pritchard; Ian Tomlinson; Mary-Claire King; Ephrat Levy-Lahad; Tamar Peretz; Yael Goldberg
Journal:  Gastroenterology       Date:  2017-02-24       Impact factor: 22.682

3.  Clinical and molecular features of the hereditary mixed polyposis syndrome.

Authors:  S C Whitelaw; V A Murday; I P Tomlinson; H J Thomas; S Cottrell; A Ginsberg; S Bukofzer; S V Hodgson; R B Skudowitz; J R Jass; I C Talbot; J M Northover; W F Bodmer; E Solomon
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

4.  Bmp signaling is required for intestinal growth and morphogenesis.

Authors:  Lorene E Batts; D Brent Polk; Raymond N Dubois; Holger Kulessa
Journal:  Dev Dyn       Date:  2006-06       Impact factor: 3.780

5.  An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.

Authors:  E E M Jaeger; K L Woodford-Richens; M Lockett; A J Rowan; E J Sawyer; K Heinimann; P Rozen; V A Murday; S C Whitelaw; A Ginsberg; W S Atkin; H T Lynch; M C Southey; H Debinski; C Eng; W F Bodmer; I C Talbot; S V Hodgson; H J W Thomas; I P M Tomlinson
Journal:  Am J Hum Genet       Date:  2003-04-14       Impact factor: 11.025

6.  Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendations.

Authors:  James Ziai; Ellen Matloff; Jaehyuk Choi; Ninani Kombo; Miguel Materin; Allen E Bale
Journal:  Genet Res (Camb)       Date:  2016-03-07       Impact factor: 1.588

Review 7.  BRCA1 and BRCA2 mutations and the risk for colorectal cancer.

Authors:  V Sopik; C Phelan; C Cybulski; S A Narod
Journal:  Clin Genet       Date:  2014-10-21       Impact factor: 4.438

8.  Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.

Authors:  Hayley Davis; Shazia Irshad; Mukesh Bansal; Hannah Rafferty; Tatjana Boitsova; Chiara Bardella; Emma Jaeger; Annabelle Lewis; Luke Freeman-Mills; Francesc Castro Giner; Pedro Rodenas-Cuadrado; Sreelakshmi Mallappa; Susan Clark; Huw Thomas; Rosemary Jeffery; Richard Poulsom; Manuel Rodriguez-Justo; Marco Novelli; Runjan Chetty; Andrew Silver; Owen James Sansom; Florian R Greten; Lai Mun Wang; James Edward East; Ian Tomlinson; Simon John Leedham
Journal:  Nat Med       Date:  2014-12-01       Impact factor: 53.440

9.  GREM1 and POLE variants in hereditary colorectal cancer syndromes.

Authors:  Anna Rohlin; Frida Eiengård; Ulf Lundstam; Theofanis Zagoras; Staffan Nilsson; Anders Edsjö; Jan Pedersen; Janhenry Svensson; Stefan Skullman; B Göran Karlsson; Jan Björk; Margareta Nordling
Journal:  Genes Chromosomes Cancer       Date:  2015-10-23       Impact factor: 5.006

10.  Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.

Authors:  Emma Jaeger; Simon Leedham; Annabelle Lewis; Stefania Segditsas; Martin Becker; Pedro Rodenas Cuadrado; Hayley Davis; Kulvinder Kaur; Karl Heinimann; Kimberley Howarth; James East; Jenny Taylor; Huw Thomas; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

View more
  4 in total

1.  Gastrointestinal Polyposis in Pediatric Patients.

Authors:  Suzanne P MacFarland; Kristin Zelley; Bryson W Katona; Benjamin J Wilkins; Garrett M Brodeur; Petar Mamula
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 2.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

Review 3.  Incorporating Colorectal Cancer Genetic Risk Assessment into Gastroenterology Practice.

Authors:  Benjamin Stern; Thomas McGarrity; Maria Baker
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

4.  SNPs associated with colorectal cancer at 15q13.3 affect risk enhancers that modulate GREM1 gene expression.

Authors:  Barbara K Fortini; Stephanie Tring; Matthew A Devall; Mourad Wagdy Ali; Sarah J Plummer; Graham Casey
Journal:  Hum Mutat       Date:  2021-02-02       Impact factor: 4.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.